Interesting idea... how about we ask Dr. William Makis (oncologist), Dr. Ryan Cole (pathologist) and/or Dr. Trozzi (ER physician turned advocate for safe pandemic interventions) as to how much it would cost them to
i) do preliminary research (such as on biopsies or liquid biopsies from patients with and without turbo cancers versus healthy controls), and if viable ii) full blown studies. If the lab is already well equipped and doing similar research, then the costs would be much lower. Usually preliminary studies are around $150,000 while full blown would be in the millions. Centers of Excellence generally receive about 1 to 5 million dollar grants per year.
From a fund-raising standpoint, I would wonder if this could be combined with the DNA integration testing that Dr Bulkhaults has talked about after repeating McKernan's SV40 and foreign DNA discoveries. If the research is pointed in the right direction and is backed by some of the larger Substack authors, then raising $150k should not be a problem. Please email me to discuss further. Thanks for all that you are doing.
As I hinted above, one could simply extract DNA from plasma (representing recently lysed cells) and could look for a SV40 integration signal over genomic equivalents in the same manner that I did real time ddCt PCR for showing 5 fold integrated HERV-K102 in genomic DNA for women resistant to HIV infection [Laderoute MP et al, 2007 and 2015] not found in healthy controls and also not in HIV patients. It might be useful to enhance detection by doing a pre sample on a patient with turbo cancer and say one, two, or three days after ivermectin treatment in the hopes that ivermectin would reverse apoptosis resistance of the turbo cancer, and thus, dump a high amount of tumor DNA into the plasma to improve signal.
Who does fund the research that is bad-for-business?
I can't seem to remember.
;-(
Do you have an estimate of how much the research would cost? There might be a crowd funding opportunity if we get others behind it.
Interesting idea... how about we ask Dr. William Makis (oncologist), Dr. Ryan Cole (pathologist) and/or Dr. Trozzi (ER physician turned advocate for safe pandemic interventions) as to how much it would cost them to
i) do preliminary research (such as on biopsies or liquid biopsies from patients with and without turbo cancers versus healthy controls), and if viable ii) full blown studies. If the lab is already well equipped and doing similar research, then the costs would be much lower. Usually preliminary studies are around $150,000 while full blown would be in the millions. Centers of Excellence generally receive about 1 to 5 million dollar grants per year.
From a fund-raising standpoint, I would wonder if this could be combined with the DNA integration testing that Dr Bulkhaults has talked about after repeating McKernan's SV40 and foreign DNA discoveries. If the research is pointed in the right direction and is backed by some of the larger Substack authors, then raising $150k should not be a problem. Please email me to discuss further. Thanks for all that you are doing.
As I hinted above, one could simply extract DNA from plasma (representing recently lysed cells) and could look for a SV40 integration signal over genomic equivalents in the same manner that I did real time ddCt PCR for showing 5 fold integrated HERV-K102 in genomic DNA for women resistant to HIV infection [Laderoute MP et al, 2007 and 2015] not found in healthy controls and also not in HIV patients. It might be useful to enhance detection by doing a pre sample on a patient with turbo cancer and say one, two, or three days after ivermectin treatment in the hopes that ivermectin would reverse apoptosis resistance of the turbo cancer, and thus, dump a high amount of tumor DNA into the plasma to improve signal.
Please send a message to me at twitter.com/hervk102 as there are too many Dan Perrier's on twitter. Thanks.